74 results
Page 2 of 4
424B3
4fqnx59s hlcp
19 Oct 22
Prospectus supplement
6:10am
8-K
EX-99.1
j5y5u32k7 m884s30
8 Sep 22
InMed Pharmaceuticals Provides Update on its Core Research and Development Programs and BayMedica Business
4:02pm
8-K
EX-99.1
f6xj0x6w50lehvydmfi2
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
8-K
EX-10.1
t0z2p0q4ly8esorz0xq
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
424B3
ppunmq5fucq78
6 Jul 22
Prospectus supplement
2:43pm
424B5
dkrni3kb6z8
3 Jun 22
Prospectus supplement for primary offering
9:45pm
8-K
EX-99.1
uxnc5
18 May 22
InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update
1:34pm
8-K
EX-99.1
q4so9
28 Apr 22
Regulation FD Disclosure
2:35pm
424B3
50ivdiqz2xjy6pya
25 Apr 22
Prospectus supplement
5:02pm
424B3
5imkob9muyljo l6
7 Apr 22
Prospectus supplement
4:46pm
8-K
EX-99.1
qggh2bfc 83
18 Mar 22
InMed Announces Management Changes
1:02pm